REMUREL

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug REMUREL contains one active pharmaceutical ingredient (API):

1 Glatiramer UNII 5M691HL4BO - GLATIRAMER ACETATE

Glatiramer is presumed to involve modulation of immune processes. Glatiramer is licensed for reduced frequency of relapses in relapsing-remitting multiple sclerosis. Read about Glatiramer

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AX13	Glatiramer acetate	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1659359, 1659360, 1659371, 1659382, 1716982, 1716993, 1717006
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-589516554
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073937, 1080248, 1080249, 1080250, 1084425, 1084426, 1084427
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100367418, 100371259
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68201001, W68201002, W68201003, W68309001, W68309002, W68309003, W68309004